Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1 results about "Liver perfusion" patented technology

Ischemic hepatitis, also known as ischemic hepatopathy or shock liver, is a condition defined as an acute liver injury caused by insufficient blood flow (and consequently insufficient oxygen delivery) to the liver. The decreased blood flow (perfusion) to the liver is usually due to shock or low blood pressure.

Whole-liver bioartificial liver system

ActiveCN112604051AAdjust the perfusion pressureGood internal and external environmentOther blood circulation devicesWhole liverBlood plasma
The invention provides a whole-liver bioartificial liver system which comprises a plasma separation and circulation passage, a liver perfusion circulation passage, a plasma separation and return circulation passage and a blood storage tank which are relatively independent, and the blood storage tank is used for mixing plasma of a patient and an in-vitro liver oxygen carrier; the plasma separation and circulation passage comprises a blood input pipeline, a first plasma separation pipeline and a blood return pipeline, and the first plasma separation pipeline is connected with the blood storage tank; the liver perfusion circulation path comprises a biochemical purification pipeline provided with a whole liver perfusion assembly, and the biochemical purification pipeline is connected with the blood storage tank; the plasma separation and return circulation passage comprises a second plasma separation circulation pipeline and a plasma return pipeline, the input end of the second plasma separation circulation pipeline is connected with the output end of the blood storage tank, and the plasma return pipeline is connected between the second plasma separation circulation pipeline and the blood return pipeline. By arranging the blood storage tank, the perfusion pressure, flow and flow velocity of the in-vitro liver can be better adjusted, the perfusion efficiency is improved, and the circulation time is shortened.
Owner:GUANGDONG UNISUN BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products